SynthesisFrontiers in medicine2025
Environmental cadmium exposure and the risk of kidney stones: a systematic review and dose-response meta-analysis.
Synthesis in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Recent studies have investigated the relationship between cadmium exposure and kidney stones. Nevertheless, the results remain controversial. Therefore, we performed a comprehensive systematic review and meta-analysis based on the latest evidence to address gaps in the research. Methods: Medline, Embase, and the Web of Science databases were searched to identify relevant studies up until 31 July 2024. Characteristics and outcomes of the included studies were extracted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and the Meta-analyses of Observational Studies in Epidemiology (MOOSE) guidelines. A random effects model was used to determine the association between cadmium exposure and the risk of kidney stones. Results: A total of 17 studies involving 159,011 individuals were included in the meta-analysis. When comparing the highest versus lowest cadmium exposure levels, the overall relative risk (RR) for kidney stones was 1.19 [95% confidence interval (CI): 1.10-1.29]. Subgroup analysis showed that urinary (RR = 1.19; 95%CI: 1.08-1.30) and blood (RR = 1.49; 95% CI: 1.10-2.02) cadmium levels were associated with an increased risk of kidney stones. In contrast to non-cadmium-contaminated areas, both blood (RR = 1.08; 95% CI: 1.00-1.15) and urinary (RR = 1.16; 95% CI: 1.05-1.27) cadmium levels were associated with an increased risk of kidney stones in cadmium-contaminated areas. In the dose-response meta-analysis, we observed a consistent linear positive association between cadmium exposure and the risk of kidney stones. The overall RR for every 1.0 μg/L increase in urinary cadmium levels was 1.07 (95% CI: 1.01-1.13). Conclusion: Our findings suggest that cadmium exposure is associated with the risk of kidney stones. These findings reinforce the importance of environmental cadmium exposure as a risk factor for kidney stones, extending beyond the influence of conventional risk factors. Efforts to reduce cadmium exposure in the population may help reduce the individual, economic, and societal burdens associated with kidney stones. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/myprospero.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.